The Dialysis Access Center

Filter Your Results

 

News

 

Stent Tek Receives Funding to Advance Development of Its ePath AVF Device for Dialysis Access

August 30, 2017 -- Stent Tek, a United Kingdom -- based company specializing in endovascular solutions, announced that it has successfully closed a Series A funding round with…

FDA Approves Indication for Bard's Lutonix 035 DCB to Treat Dysfunctional AV Fistulas

August 28, 2017 -- Bard Peripheral Vascular, Inc. announced that the US Food and Drug Administration (FDA) has approved a new indication for the Lutonix 035 drug-coated balloo…

Initial Results Published From Small Study of TVA Medical's everlinQ System for Hemodialysis Access

August 23, 2017 -- The first results were published from an eight-patient evaluation of endovascular creation of an arteriovenous fistula (AVF) for hemodialysis access using t…

FDA Approves IDE for Clinical Study of Laminate Medical Technologies' VasQ Device

August 1, 2017 -- Laminate Medical Technologies, an Israel-based company, announced that it has received investigational device exemption approval from the US Food and Drug Ad…

Holy Name Medical Center Enrolls Its First Patient in Medtronic's IN.PACT AV Access DCB Study

July 19, 2017 -- Holy Name Medical Center in Teaneck, New Jersey, recently announced that it has enrolled the center's first patient in the IN.PACT Arteriovenous (AV) Acce…

Fresenius Vascular Care Changes Name to Azura

June 20, 2017 -- Fresenius Vascular Care announced its new name, Azura Vascular Care, as part of a strategic rebranding initiative. A phased rollout of the new brand across al…

Twelve-Month NEAT Results Published for TVA Medical's everlinQ endoAVF System

June 15, 2017 -- TVA Medical, Inc. announced that 12-month results from the Novel Endovascular Access Trial (NEAT) were published online by Charmaine E. Lok, MD, et al in Amer…

Paclitaxel Versus Plain Balloon Angioplasty Compared in Treatment of Symptomatic Central Venous Stenosis in Dialysis Access

June 14, 2017 -- Results from a randomized controlled trial comparing the clinically assessed intervention-free period (IFP) of paclitaxel-coated balloon (PCB) angioplasty ver…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.